Connacht Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Connacht Asset Management’s Portfolio CRNX Stock Details CRNX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$217K	Sell
2023 Q2	$224K	Sell
2023 Q1	$215K	Buy
2022 Q4	$226K	Sell
2022 Q3	$297K	Buy
2022 Q2	$210K	Buy